Vivodyne
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3000 Marina Blvd Ste 200, Brisbane, Cali...Website
www.vivodyne.comRevenue
$10.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Vivodyne
Vivodyne is rendering inaccurate animal testing obsolete, using automated robotic platforms and AI to grow and analyze thousands of fully functional human tissues. Pharmaceutical companies historically have spent millions on clinical trials destined to fail 95% of the time because animal models are poor predictors of human biology. Vivodyne solves this problem by providing unprecedented, clinically relevant human data at massive scale. Already used by most top pharma companies, Vivodynes platform significantly reduces trial risk, accelerates drug discovery, and brings safer, more effective therapies to patients faster.Explore more
Vivodyne Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vivodyne your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Vivodyne
Funding: Get notified immidiatlly once Vivodyne has new funding data
Product Launch: Get notified when Vivodyne launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Vivodyne has recently received funding, and reach out quickly before it becomes old news!
Vivodyne, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Vivodyne had a recent Job posting/layoffs
Check out if Vivodyne is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Vivodyne recently announced quarterly report
Recommended Actions
Find VP level buyers at Vivodyne
Find more new buyers
Compare Similar Companies to Vivodyne
Compare insights from companies similar to Vivodyne, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vivodyne is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Vivodyne is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Vivodyne.
Vivodyne financials insights
Gather financial insights about Vivodyne, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Angel/Seed
$38M
2025
Series A
$40M
Vivodyne Tech Stack
A closer look at the technologies used by Vivodyne
Most Recent Scoops
Open Position
Open Position
Left Company
Executive Move
Executive Moves, Left Company
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Funding
Funding
Vivodyne News & Media
Vivodyne Appoints Julie O'Shaughnessy as Chief Operating Officer
PHILADELPHIA--(BUSINESS WIRE)-- #AI--Vivodyne Appoints Julie O'Shaughnessy as Chief Operating OfficerVivodyne Appoints Elliot Menschik, M.D., Ph.D., as Chief Technology Officer
PHILADELPHIA--(BUSINESS WIRE)-- #AI--Vivodyne Appoints Elliot Menschik, M.D., Ph.D., as Chief Technology OfficerPhilly Money Moves: Biotech firm Vivodyne raised $38M for lab-grown organ development
Plus, Aro Biotherapeutics raised a $41.5 million Series B, the Economy League of Greater Philadelphia received a $300,000 grant from JPMorgan Chase, and more local funding news.Vivodyne Secures $38M for AI-Powered Drug Discovery Platform - HIT Consultant
Vivodyne, a biotech company that accelerates AI-powered drug discovery by testing therapies on lab-grown human organs raises $38M
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vivodyne
Sign Up For FreeTo access detailed company insights
Vivodyne is rendering inaccurate animal testing obsolete, using automated robotic platforms and AI to grow and analyze thousands of fully functional human tissues. Pharmaceutical companies historically have spent millions on clinical trials destined to fail 95% of the time because animal models are poor predictors of human biology. Vivodyne solves... Read More
